Sofosbuvir is a prescription antiviral medication used to treat chronic hepatitis C virus (HCV) infection in adults. It is the first approved medication in a new class of direct-acting antivirals (DAAs) that work by blocking the enzyme that HCV needs to replicate. It is taken in combination with other medications and is available in tablet form. Sofosbuvir has been shown to be effective in treating all major genotypes of HCV without the need for interferon or ribavirin. It is generally well tolerated, with few side effects.
Sofosbuvir is a medication specifically used to treat chronic Hepatitis C infection, a viral infection that attacks the liver [1, 2, 3]. Here's a breakdown of its key points:
Function:
- Sofosbuvir belongs to a class of drugs called nucleotide analog inhibitors. It works by interfering with the Hepatitis C virus's ability to replicate (make copies of itself) within the body's cells [1, 2]. This helps reduce the viral load and allows the immune system to fight the infection more effectively.
Use in Hepatitis C Treatment:
- Sofosbuvir is not used alone. It's always prescribed in combination with other antiviral medications, depending on the specific type (genotype) of Hepatitis C infection and other factors [2, 3]. Examples of combination drugs include ledipasvir, daclatasvir, and ribavirin.
Benefits:
- Sofosbuvir-based treatment regimens have revolutionized Hepatitis C therapy. They offer high cure rates (over 90% in most cases) with shorter treatment durations (typically 12 to 24 weeks) compared to older treatments [2, 3].
- Sofosbuvir is also generally well-tolerated with fewer side effects compared to older therapies.